-
www.ahrq.gov/sites/default/files/2024-07/ashton-report.pdf
January 01, 2024 - Final Progress Report: Racial and Ethnic Variations in Medical Interactions
Title of Project
Racial and Ethnic Variations in Medical Interactions
Principal Investigator and Team Members
Carol M. Ashton, MD, MPH (PI), Tracie C. Collins, MD, MPH, Coreen Domingo, MPH, Howard S. Gordon,
MD…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
February 01, 2020 - Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report
1
Follow-up Visits for Children Who Are Obese or
Overweight with a Weight-Related Comorbidity
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Visits for Children Who Are Obese or Overweight wi…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
July 01, 2019 - CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children
1
Documentation of BMI Percentile and Weight
Classification for Children
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of BMI Percentile and Weight Classification for Children
1.B. Measure Number
0230
1…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-fullreport.pdf
May 01, 2018 - Rate of Emergency Department Visit Use for Children Managed for Identifiable Asthma
1
Rate of Emergency Department Visit Use for Children
Managed for Identifiable Asthma
Section 1. Basic Measure Information
1.A. Measure Name
CAPQuaM PQMP Asthma I: Rate of Emergency Department Visit Use for Children Managed
for…
-
cdsic.ahrq.gov/sites/default/files/2024-10/IAS_Key%20Factors%20and%20Considerations%20for%20Assessing%20the%20Value%20of%20PC%20CDS.pdf
January 01, 2024 - Implementation, Adoption, and Scaling Workgroup: Key Factors and Considerations for Assessing the Value of Patient-Centered Clinical Decision Support
Implementation, Adoption, and
Scaling Workgroup: Key Factors
and Considerations for Assessing
the Value of Patient-Centered
Clinical Decision Support
…
-
hcup-us.ahrq.gov/reports/methods/2011_05.pdf
January 01, 2011 - Microsoft Word - POA Methods 11_01.doc
HCUP Methods Series
kbr33831
Contact Information:
Healthcare Cost and Utilization Project (HCUP)
Agency for Healthcare Research and Quality
540 Gaither Road
Rockville, MD 20850
http://www.hcup-us.ahrq.gov
For Technical Assistance with HCUP Products:
Email:…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
December 15, 2010 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Falls Prevention in Older Adults: Counseling and Preventive Medication
December 15, 2010
Recommendations made by the USPSTF are independent o…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
April 25, 2017 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Preeclampsia: Screening
April 25, 2017
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed a…
-
meps.ahrq.gov/data_stats/nhc/sam-fac2.pdf
September 30, 1997 - OMB # 0935-0099
EXPIRES: 09/30/97
PSF ID #:
INTERVIEWER NAME:
INTERVIEWER ID:
DATE OF INTERVIEW: ________/______/_______
MONTH DAY YEAR
TIME INTERVIEW BEGAN: am/pm
Department of Health and Human Services
Public Health Service
Agency for Health Care Policy and Research
and
National Center for Health Statistics
…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
September 01, 2002 - Screening for Postmenopausal Osteoporosis: A Summary of the Evidence
Epidemiology
Half of all postmenopausal women will have an
osteoporosis-related fracture during their lives,
including one-quarter who will develop a vertebral
deformity1 and 15% who will suffer a hip fracture.2
Hip fractures are associated with h…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - No deaths occurred.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
June 01, 2015 - population and are a leading
cause of illness, disability, and mortality,1 accounting for 7 out of 10 deaths
-
hcup-us.ahrq.gov/db/nation/neds/NEDS2019Introduction.pdf
September 01, 2021 - result in an admission to that hospital (e.g., treat-and-release
visits, transfers to another hospital, deaths
-
hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2015.jsp
January 01, 2015 - result in an admission to that hospital (e.g., treat-and-release visits, transfers to another hospital, deaths
-
hcup-us.ahrq.gov/db/nation/neds/NEDS2018Introduction.pdf
November 01, 2020 - result in an admission to that hospital (e.g., treat-and-release
visits, transfers to another hospital, deaths
-
hcup-us.ahrq.gov/db/nation/neds/NEDS_Introduction_2019.jsp
January 01, 2019 - result in an admission to that hospital (e.g., treat-and-release visits, transfers to another hospital, deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Premature deaths due to cancer,
cardiovascular diseases and suicide in particular are relevant since
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - their weight loss.6 In reporting on ReShape Duo’s safety, the authors
reported the following:6
No deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - their weight loss.6 In reporting on ReShape Duo’s safety, the authors
reported the following:6
No deaths